A Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler Imaging
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The randomized LITE study will compare liposomal doxorubin versus standard epirubicin in the
treatment of female breast cancer. In order to detect as early as possible post-chemotherapy
cardiotoxicity, tissue Doppler imaging parameters elicited at transthoracic echocardiography
will be used and will constitute the primary and co-primary end-points.